In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: Stratified analysis by vancomycin MIC

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 5, 2011, Pages 346-351

  Kao, Tsui Mai ^a   Wang, Jann Tay ^a   Weng, Chia Min ^a   Chen, Yee Chun ^a   Chang, Shan Chwen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Executive Yuan ^*  (Taiwan)

Author keywords

Blood isolates; In vitro activity; Molecular epidemiology; MRSA

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; MINOCYCLINE; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD SAMPLING; HUMAN; HUMAN CELL; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; TAIWAN;

ACETAMIDES; ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; DAPTOMYCIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; TAIWAN; VANCOMYCIN;

EID: 80053644389     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.01.037     Document Type: Article

References (22)

1. Ho M., McDonald L.C., Lauderdale T.L., Yeh L.L., Chen P.C., Shiau Y.R. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999, 32:239-249.
2. Chamis A.L., Peterson G.E., Cabell C.H., Corey G.R., Sorrentino R.A., Greenfield R.A., et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001, 104:1029-1033.
3. Salmenlinna S., Lyytikinen O., Kotilainen P., Scotford R., Siren E., Vuopio-Varkila J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis 2000, 19:101-107.
4. Wang J.T., Chen Y.C., Yang T.L., Chang S.C. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002, 42:199-203.
5. Wang J.T., Fang C.T., Chen Y.C., Wu C.L., Chen M.L., Chang S.C. Staphylococcal cassette chromosome mec in MRSA, Taiwan. Emerg Infect Dis 2007, 13:494-497.
6. Chen C.J., Hsueh P.R., Su L.H., Chiu C.H., Lin T.Y., Huang Y.C. Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan. Diagn Microbiol Infect Dis 2009, 65:199-201.
7. D'Agata E.M., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48:274-284.
8. Davis S.L., Rybak M.J., Amjad M., Kaatz G.W., McKinnon P.S. Characteristics of patients with healthcare-associated infection due to SCC mec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006, 27:1025-1031.
9. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008, 46:795-798.
10. Lodise T.P., Graves J., Evans A., Graffunder E., Helmecke M., Lomaestro B.M., et al. Relationship between vancomycin MIC and failure among patients with MRSA bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008, 52:3315-3320.
11. Hidayat L.K., Hsu D.I., Quist R., Shriner K.A., Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006, 166:2138-2144.
12. Micek S.T. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2007, 45:S184-S190.
13. Drees M., Boucher H. New agents for Staphylococcus aureus endocarditis. Curr Opin Infect Dis 2006, 19:544-550.
14. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
15. Seybold U., Kourbatova E.V., Johnson J.G., Halvosa S.J., Wang Y.F., King M.D., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infection. Clin Infect Dis 2006, 42:647-656.
16. Wang J.L., Wang J.T., Chen S.Y., Hsueh P.R., Kung H.C., Chen Y.C., et al. Adult methicillin-resistant Staphylococus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene. Diagn Microbiol Infect Dis 2007, 59:365-371.
17. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard-seventh edition, M7-A7 2006, Clinical and Laboratory Standards Institute, Wayne, PA.
18. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement, M100-S19 2009, Clinical and Laboratory Standards Institute, Wayne, PA.
19. The European Committee for Antimicrobial Susceptibility Testing (EUCAST) Steering Committee EUCAST technical note on tigecycline. Clin Microbiol Infect 2006, 12:1147-1149.
20. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2002, 38:1008-1015.
21. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
22. Shorr A.F., Kunkel M.J., Kollef M. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. J Antimicrob Chemother 2005, 56:923-929.